Literature DB >> 11832462

Selective modulation of PKC isozymes by inflammation in canine colonic circular muscle cells.

Irshad Ali1, Sushil K Sarna.   

Abstract

BACKGROUND & AIMS: Protein kinase C (PKC) is a key signaling molecule in excitation-contraction coupling in several types of smooth muscle cells. We investigated whether the attenuated contraction in inflamed colon cells is caused by alterations in the expression, distribution, and activation of specific PKC isozymes.
METHODS: Kinase assays, immunofluorescence imaging, and Western immunoblotting were performed on single circular smooth muscle cells obtained from the normal dog colon as well as from colon with experimental colitis induced by mucosal exposure to ethanol and acetic acid, to determine the distribution, expression, and activation of PKC isozymes.
RESULTS: Classical (alpha, beta, and gamma), novel (delta and epsilon), and the atypical PKC (iota, lambda, and zeta) isozymes were detected in colonic circular muscle cells. The expression of PKC alpha, beta, and epsilon isozymes was down-regulated, whereas that of PKC iota and lambda isozymes was up-regulated; other isozymes were not affected by inflammation. Acetylcholine (ACh) treatment translocated only the PKC alpha, beta, and epsilon isozymes from the cytosol to the membrane in normal cells; this translocation was absent in inflamed colon cells. Immunofluorescence imaging confirmed the translocation of PKC alpha from the cytosol to the membrane in response to ACh in normal cells. PKC inhibitors, chelerythrine, and myristoylated peptides to alpha, beta, and epsilon isozymes inhibited the contractile response to ACh in normal, but not in inflamed, cells. PKC iota and lambda did not participate in the contractile response to ACh.
CONCLUSIONS: ACh-induced contraction is mediated by PKC alpha, beta, and epsilon isozymes in normal colonic circular muscle cells. Contractile dysfunction in inflamed colon cells is, in part, caused by decreased expression and impaired activation of specific PKC isozymes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11832462     DOI: 10.1053/gast.2002.31215

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  7 in total

1.  Protein kinase C isoforms in the enteric nervous system.

Authors:  Daniel P Poole; Billie Hunne; Heather L Robbins; John B Furness
Journal:  Histochem Cell Biol       Date:  2003-06-13       Impact factor: 4.304

2.  The distribution of PKC isoforms in enteric neurons, muscle and interstitial cells of the human intestine.

Authors:  John B Furness; Anderson J Hind; Katrina Ngui; Heather L Robbins; Nadine Clerc; Thierry Merrot; Joseph J Tjandra; Daniel P Poole
Journal:  Histochem Cell Biol       Date:  2006-05-30       Impact factor: 4.304

3.  RhoA/ROCK pathway is the major molecular determinant of basal tone in intact human internal anal sphincter.

Authors:  Satish Rattan; Jagmohan Singh
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-01-12       Impact factor: 4.052

4.  Modulation of protein kinase C (PKC)-mediated contraction and the possible role of PKC epsilon in rat mesenteric arteries.

Authors:  Yuichi Shirasawa; Travis J Rutland; Jennifer L Young; David A Dean; Benoit N Joseph
Journal:  Front Biosci       Date:  2003-05-01

5.  Conventional-type protein kinase C contributes to phorbol ester-induced inhibition of rat myometrial tension.

Authors:  Bokyung Kim; Yoon-Sun Kim; Jiyun Ahn; Junghwan Kim; SungIl Cho; Kyung-Jong Won; Hiroshi Ozaki; Hideaki Karaki; Sang-Mok Lee
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

6.  Bioengineered human IAS reconstructs with functional and molecular properties similar to intact IAS.

Authors:  Jagmohan Singh; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-07-12       Impact factor: 4.052

7.  Chai-Qin-Cheng-Qi Decoction and Carbachol Improve Intestinal Motility by Regulating Protein Kinase C-Mediated Ca2+ Release in Colonic Smooth Muscle Cells in Rats with Acute Necrotising Pancreatitis.

Authors:  Chen-Long Zhang; Zi-Qi Lin; Rui-Jie Luo; Xiao-Xin Zhang; Jia Guo; Wei Wu; Na Shi; Li-Hui Deng; Wei-Wei Chen; Xiao-Ying Zhang; Shameena Bharucha; Wei Huang; Robert Sutton; John A Windsor; Ping Xue; Qing Xia
Journal:  Evid Based Complement Alternat Med       Date:  2017-04-26       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.